Two Sigma Investments
NVAX icon

Two Sigma Investments’s Novavax NVAX Stock Holding History

Two Sigma Investments’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-53,500
Closed -$371K – 3191
2023
Q1 		$371K Buy
+53,500
New +$492K ﹤0.01% 2329

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments's NVAX Position: Q1 2026 in Review

Two Sigma Investments reduced its Novavax (NVAX) stake by 1.4% in Q1 2026, selling an estimated $81.7K and leaving 614,799 shares worth $5M. The position accounts for ﹤0.01% of the portfolio, ranked #1976.

Two Sigma Investments first reported a position in NVAX in Q3 2013 and has held it in 22 quarters since. The position peaked at $15.6M in Q3 2020. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Two Sigma Investments held 614,799 shares of Novavax worth $5M as of Q1 2026.
  • Two Sigma Investments sold 9,013 Novavax shares in Q1 2026, an estimated $81.7K.
  • Novavax made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #1976 holding.
  • Two Sigma Investments first reported a position in Novavax in Q3 2013 and has held it in 22 quarters since.
  • Two Sigma Investments's Novavax position peaked at $15.6M in Q3 2020.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.